查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1950453

可脱卸式弹簧圈栓塞系统市场：依输送机制、配置、弹簧圈类型、最终用户和应用划分－全球预测，2026-2032年

Detachable Coil Embolization System Market by Delivery Mechanism, Configuration, Coil Type, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，可脱卸弹簧圈栓塞系统市场规模将达到 13.8 亿美元，到 2026 年将达到 15 亿美元。预计到 2032 年，该市场规模将达到 28.5 亿美元，复合年增长率为 10.85%。

关键市场统计数据
基准年 2025 13.8亿美元
预计年份：2026年 15亿美元
预测年份 2032 28.5亿美元
复合年增长率 (%) 10.85%

权威地说明了可脱卸弹簧圈栓塞技术的发展历程、临床应用、监管驱动因素及其对介入治疗路径的影响。

可脱卸式弹簧圈栓塞系统已成为介入性神经放射学和周边血管治疗的主要手段，为临床医生提供了动脉瘤和特定血管病变的可控栓塞方案。这些装置旨在实现弹簧圈在目标血管内的精准定位和释放，融合了材料科学、导管导航和释放技术的最新进展。临床医生依靠弹簧圈的脱卸可靠性和结构设计来最大限度地减少手术併发症，例如弹簧圈移位、血栓性栓塞症或动脉瘤闭塞不完全。同时，医疗系统则致力于提高治疗流程效率、手术吞吐量和患者预后。

医疗器材创新、临床应用路径、监管证据要求以及供应链动态的变革性变化正在重塑产业格局。

技术、临床实务和商业策略等多面向因素的融合正在重塑可脱卸弹簧圈栓塞术的格局。脱卸机制和涂层化学技术的进步使得对释放动力学的精确控製成为可能，从而拓展了其适应症，并提高了介入神经放射学和周边血管专科医师的接受度。同时，血管内治疗平台和辅助器械的激增带来了整合方面的挑战和互通性的机会，这些都影响着采购决策和临床培训重点。

对2025年关税对製造商、供应商和临床服务提供者的成本、采购和营运调整的连锁反应进行分析评估

主要贸易国征收关税可能会透过多种管道对可拆卸线圈生态系统产生连锁反应，因此需要为预计于2025年生效的变化製定周密的策略规划。对零件进口、特殊合金或成品医疗设备征收关税将增加到岸成本，迫使製造商重新评估其筹资策略、库存管理政策和定价技巧。为此，企业可能采取近岸外包、双重采购或垂直整合等措施，以维持毛利率和交货可靠性。

基于细分的关键洞察将终端用户环境、脱离机制、线圈配置、临床应用和材料技术与采用驱动因素联繫起来

详细的细分框架阐明了临床需求领域以及产品设计应如何与临床工作流程相契合。基于最终用户的采用趋势在门诊手术中心和医院之间存在差异，而医院又进一步细分为社区医院和教学医院。在这些环境中，采购选择受手术复杂性、病例组合以及取得专业影像设备等因素驱动。门诊环境优先考虑能够实现可预测、高效手术和快速復健通讯协定的设备，而教学医院则倾向于优先考虑适用于复杂病例和培训需求的、功能全面且基于循证医学的平台。

关键区域的区域性应用差异和供应链考量将影响监管策略、临床应用和商业性优先顺序。

区域趋势透过法规结构、报销模式、临床基础设施和供应商网路的差异，影响技术的推广应用路径。在美洲，高手术量、先进的三级医疗中心和完善的报销机制促进了先进消融技术和新型线圈化学成分的快速应用。然而，支付方的严格审查和基于价值的采购策略，正日益加大对价格和疗效的压力，要求製造商证明其产品具有相对的临床优势和持续的性能。在欧洲、中东和非洲地区，监管时间表和医院资金筹措的差异导致了不同的技术推广速度。欧洲领先的医疗中心在早期采用者和循证实践方面发挥着重要作用，而其他市场则优先考虑价格和分销的可靠性，从而推动了分级产品供应和本地化伙伴关係。

竞争格局分析揭示了技术差异化、证据策略、伙伴关係和供应链韧性如何塑造供应商优势。

可拆卸线圈领域的竞争格局取决于技术差异化、证据累积和渠道执行的综合作用。成熟的医疗设备製造商利用深厚的临床关係、全面的培训项目和全球分销网络来推动产品应用，而新兴企业专注于诸如新型释放化学、先进涂层和组件几何形状等细分领域的创新，以吸引专家关注并积累临床证据。契约製造製造商和精密组件供应商正日益扮演战略合作伙伴的角色，在无需大量资本投入的情况下，实现快速原型製作和柔软性的批量生产。

为产业领导者提供可操作的策略重点，以增强临床应用、供应链韧性、证据产生和商业性差异化。

产业领导者应优先考虑切实可行的策略措施，以巩固市场地位并支持临床应用。首先，应投资于有针对性的临床证据生成，以解决临床医生对长期封锁持久性和再治疗率的担忧，并利用实用性註册研究和多中心观察性研究来补充对照试验。这种方法将关注真实世界的临床实践，改善与支付方的沟通，并为比较疗效的讨论奠定基础。

透明的多来源调查方法结合了深度访谈、临床文献综述、监管分析和供应链分析，以确保获得可靠的见解。

本分析的调查方法整合了多方面的证据，以确保其稳健性、透明度和相关性。主要研究包括对临床医生、采购人员、监管专家和供应链经理进行结构化访谈，以收集有关设备性能、推广障碍和采购标准的第一手资料。此外，还结合了手术数据趋势、临床註册摘要和匿名化的医院采购记录，以揭示实际使用模式和采购时间轴。

这篇综述强调了协作式证据产生、供应链灵活性和客製化商业化对于确保临床和商业性成功的重要性。

本报告整合了技术、临床和商业性观点，全面概述了可脱卸弹簧圈栓塞术的现状。器材创新不断提升脱卸精准度、弹簧圈形态和生物相容性涂层，而临床应用则越来越依赖可验证的真实世界疗效和无缝衔接的手术流程。供应链和政策的变化增加了营运的复杂性，迫使製造商和医疗服务提供者寻求多元化的采购管道、实证实践以及以服务为导向的商业模式。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 可拆卸弹簧圈栓塞系统市场（依输送机制划分）

  • 电气分离
    • 直流电脱附
    • 电解脱附
  • 机械可拆卸
    • 微型机械夹
    • 弹簧型

9. 可拆式弹簧圈栓塞系统市场（按类型划分）

  • 3D
    • 复杂形状
    • J形
  • 2D
    • 螺旋
    • 直的

10. 可拆式弹簧圈栓塞系统市场（依弹簧圈类型划分）

  • 裸铂金
  • 生物活性
  • 水凝胶涂层

第十一章 可拆卸弹簧圈栓塞系统市场（以最终用户划分）

  • 门诊手术中心
  • 医院
    • 社区医院
    • 教学医院

第十二章 可拆卸弹簧圈栓塞系统市场（依应用领域划分）

  • 脑动脉瘤
    • 纺锤形
    • 囊状
  • 週边动脉瘤
    • 肢体
    • 内臟器官

13. 可拆式弹簧圈栓塞系统市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 可拆式弹簧圈栓塞系统市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各国可拆式弹簧圈栓塞系统市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国可拆式弹簧圈栓塞系统市场

第十七章 中国可脱卸弹簧圈栓塞系统市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Acandis GmbH & Co. KG
  • Asahi Intecc Co., Ltd.
  • Balt Extrusion SAS
  • Boston Scientific Corporation
  • Cerenovus, a Johnson & Johnson Company
  • Cook Medical LLC
  • Guerbet LLC
  • Integer Holdings Corporation
  • Johnson & Johnson
  • Kaneka Corporation
  • Lepu Medical Technology Co., Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • MicroVention, Inc.
  • Penumbra, Inc.
  • Shape Memory Medical, Inc.
  • Stryker Corporation
  • Terumo Corporation
Product Code: MRR-4F7A6D4FD873

The Detachable Coil Embolization System Market was valued at USD 1.38 billion in 2025 and is projected to grow to USD 1.50 billion in 2026, with a CAGR of 10.85%, reaching USD 2.85 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.38 billion
Estimated Year [2026] USD 1.50 billion
Forecast Year [2032] USD 2.85 billion
CAGR (%) 10.85%

An authoritative introduction framing detachable coil embolization technology evolution, clinical roles, regulatory drivers, and implications for interventional care pathways

Detachable coil embolization systems have become central to interventional neuroradiology and peripheral vascular care by offering clinicians controlled occlusion options for aneurysms and select vascular lesions. These devices, engineered to enable precise placement and detachment of coils within target vasculature, bridge advances in material science, catheter navigation, and detachment technologies. Clinicians rely on detachment reliability and coil configuration to minimize procedural complications such as coil migration, thromboembolism, or incomplete aneurysm occlusion, while health systems focus on pathway efficiency, procedural throughput, and patient outcomes.

Over recent years, design iteration has centered on optimizing coil conformability, radiopacity, and thrombogenic profiles to address a wider range of lesion morphologies and access routes. Regulatory expectations and reimbursement dynamics have driven manufacturers to invest in robust clinical evidence and post-market surveillance. As a result, stakeholders from device engineers to hospital procurement leaders are recalibrating adoption strategies based on procedural performance, operator learning curves, and compatibility with existing catheter platforms. This introduction frames the remainder of the analysis by situating device-level technical evolution within clinical decision-making, regulatory oversight, and supply chain considerations that collectively shape adoption pathways.

Transformative shifts in device innovation, clinical adoption pathways, regulatory evidence expectations, and supply chain dynamics that are redefining the industry landscape

The landscape for detachable coil embolization is being reshaped by convergent forces that span technology, clinical practice, and commercial strategy. Advances in detachment mechanisms and coating chemistries are enabling finer control of deployment dynamics, and this is translating into expanded procedural indications and greater acceptance among neurointerventionalists and peripheral specialists. Simultaneously, the proliferation of endovascular platforms and adjunctive devices is prompting integration challenges and opportunities for interoperability, thereby influencing procurement decisions and clinical training priorities.

Another transformative shift is the migration of certain procedures to lower-acuity settings, driven by improvements in device safety profiles and streamlined peri-procedural pathways. This transition is affecting case mix, capital allocation, and reimbursement negotiation. Payor and regulatory scrutiny is concurrently increasing the emphasis on demonstrable real-world outcomes and cost-effectiveness, which in turn places a premium on robust clinical registries and post-market evidence generation. Lastly, supply chain digitization, modular manufacturing approaches, and partnerships between established suppliers and nimble innovators are accelerating product iteration cycles, making speed-to-clinic and strategic alliances decisive competitive factors.

Analytical assessment of how 2025 tariff measures could propagate cost, sourcing, and operational adjustments across manufacturers, suppliers, and clinical providers

The introduction of tariff measures by major trading economies can reverberate across the detachable coil ecosystem through multiple transmission channels, and anticipated changes effective in 2025 warrant careful strategic planning. Tariffs applied to component imports, specialized alloys, or finished medical devices can increase landed costs, prompting manufacturers to reassess sourcing strategies, inventory policies, and pricing approaches. In response, firms may pursue nearshoring, dual sourcing, or vertical integration to preserve gross margins and delivery reliability.

Beyond direct cost effects, tariffs can alter supplier negotiations and lead times, creating incentives to redesign products for alternative material inputs or to qualify additional contract manufacturers. Clinical operations may feel the impact through delayed deliveries or higher unit costs, which could affect procurement cycles and hospital budgeting decisions. In parallel, regulatory compliance and customs clearance processes may require additional documentation and auditing, raising administrative overhead. Strategic responses that have emerged include supply chain mapping to identify tariff exposure, scenario planning to evaluate cost pass-through versus absorption, and accelerated supplier qualification programs to diversify risk and maintain continuity of supply.

Key segmentation-driven insights that connect end-user settings, detachment mechanics, coil configurations, clinical applications, and material technologies to adoption drivers

A granular segmentation framework clarifies where clinical demand concentrates and how product design must align with clinical workflows. Based on end user, adoption dynamics differ between Ambulatory Surgery Centers and Hospitals, with hospitals further differentiated into Community Hospitals and Teaching Hospitals; procedural complexity, case mix, and access to specialized imaging guide procurement choices across these settings. Ambulatory environments prioritize devices that enable predictable, efficient procedures and rapid recovery protocols, while teaching hospitals often prioritize versatility and evidence-based platforms suited for complex cases and training needs.

Based on delivery mechanism, clinical expectations hinge on detachment reliability and handling characteristics. Electrodetachable and Mechanical Detachable approaches present distinct user experiences, with electrodetachable technologies subdividing into DC Electrodetachment and Electrolytic Detachment variants that influence detachment timing and energy profiles, while mechanical detachable systems further divide into Micromechanical Clip and Spring Loaded architectures that prioritize tactile feedback and mechanical predictability. These distinctions shape operator preference and procedural setup.

Based on configuration, device geometry dictates conformability and lesion coverage. Three D and Two D geometries address different aneurysm morphologies, with Three D configurations further described as Complex Shape and J Shape to accommodate irregular sac anatomy, while Two D options including Helical and Straight designs optimize packing density and longitudinal control. Matching configuration to aneurysm architecture remains central to minimizing recurrence risk.

Based on application, clinical segmentation separates Cerebral Aneurysm and Peripheral Aneurysm use cases; cerebral indications are further categorized into Fusiform and Saccular lesions requiring divergent treatment philosophies, and peripheral applications split into Extremity and Visceral targets that pose different access and embolization challenges. Finally, based on coil type, materials strategy spans Bare Platinum, Bioactive, and Hydrogel Coated coils, each offering unique thrombogenic properties and interaction with healing biology. Integrating these segmentation layers enables more nuanced product positioning, clinical training programs, and procurement specifications designed to meet differentiated clinical needs.

Regional adoption nuances and supply chain considerations across major geographies that influence regulatory strategy, clinical uptake, and commercial prioritization

Regional dynamics shape adoption pathways through differences in regulatory frameworks, reimbursement models, clinical infrastructure, and supplier networks. In the Americas, high procedural volumes, developed tertiary care centers, and established reimbursement mechanisms support rapid uptake of advanced detachment technologies and novel coil chemistries; however, payor scrutiny and value-based purchasing are increasing pressure on price and outcomes, incentivizing manufacturers to demonstrate comparative clinical benefit and durable performance. In Europe, Middle East & Africa, heterogeneity in regulatory timelines and hospital funding creates a patchwork of adoption speeds; leading European centers often act as early adopters and evidence generators, while other markets emphasize affordability and distribution reliability, prompting tiered product offerings and local partnerships.

Across Asia-Pacific, expansive population bases, rising investment in interventional capabilities, and growing numbers of trained specialists are expanding the addressable base for detachable coils, although infrastructure variability means product strategies must accommodate a range of hospital capabilities and procurement models. Manufacturers and suppliers must tailor regulatory strategies, clinical training, and commercial engagement to the specific reimbursement and hospital procurement realities of each region, while also anticipating cross-border supply chain considerations that affect lead times and pricing competitiveness.

Competitive landscape analysis revealing how technological differentiation, evidence strategies, partnerships, and supply chain resilience are shaping supplier advantage

Competitive dynamics in the detachable coil space are defined by a combination of technological differentiation, evidence generation, and channel execution. Established medical device manufacturers leverage deep clinical relationships, comprehensive training programs, and global distribution networks to drive adoption, while emerging companies focus on niche innovation-such as novel detachment chemistries, advanced coatings, or configuration geometries-to capture specialist interest and create clinical proof points. Contract manufacturers and precision component suppliers are increasingly strategic partners, enabling faster prototyping and volume flexibility without significant capital expenditure.

Strategic partnerships between device developers and imaging or navigation platform providers are strengthening integrated procedural workflows, improving clinician confidence, and accelerating adoption in centers seeking streamlined solutions. Meanwhile, service models that include comprehensive training, procedural support, and outcomes tracking are proving decisive in high-stakes neurovascular procedures. Commercially, firms that align reimbursement policy support with clinician education and that invest in real-world evidence collection are better positioned to negotiate formulary placement and long-term institutional usage. Finally, supply chain resilience-characterized by diversified sourcing, responsive logistics, and regulatory compliance expertise-remains a core capability that separates reliable suppliers from more fragile entrants.

Actionable strategic priorities for industry leaders to strengthen clinical adoption, supply chain resilience, evidence generation, and commercial differentiation

Industry leaders should prioritize a set of actionable strategic moves to fortify market position and support clinical adoption. First, invest in targeted clinical evidence generation that addresses operator concerns around long-term occlusion durability and re-treatment rates, using pragmatic registries and multi-center observational studies to complement controlled trials. This approach improves payer conversations and informs comparative effectiveness discussions while being responsive to real-world practice.

Second, accelerate supply chain diversification by qualifying alternative suppliers for critical components and by developing contingency stock strategies for high-use items. Near-term actions include mapping supplier concentration risks, stress-testing logistics under tariff scenarios, and establishing rapid qualification pathways for secondary manufacturers. Third, refine product portfolios to offer clear segmentation-aligned platforms: devices tailored to ambulatory settings should emphasize ease-of-use and procedural efficiency, while offerings for teaching hospitals should prioritize versatility and training compatibility. Fourth, deepen clinical engagement through interdisciplinary training programs and simulation-based credentialing that reduce operator variability and improve clinical outcomes. Lastly, align commercial models with value-based purchasing by providing bundled service offerings that combine devices, training, and outcomes tracking to reduce institutional barriers to adoption and demonstrate tangible return on investment.

Transparent, multi-source research methodology combining primary interviews, clinical literature review, regulatory analysis, and supply chain mapping to ensure robust insights

The research methodology underpinning this analysis integrates multiple evidence streams to ensure robustness, transparency, and relevance. Primary research included structured interviews with clinicians, procurement leaders, regulatory experts, and supply chain managers to capture first-hand perspectives on device performance, adoption barriers, and purchasing criteria. These insights were supplemented by procedural data trends, clinical registry summaries, and anonymized hospital sourcing logs to illuminate real-world usage patterns and procurement timelines.

Secondary research encompassed regulatory filings, peer-reviewed clinical literature, patent landscapes, and manufacturing technology briefs to chart innovation trajectories and compliance considerations. Data validation relied on triangulation across sources, cross-checking interview findings with clinical publications and regulatory documentation. Supply chain analysis used bill-of-material mapping and logistics assessments to identify tariff exposure and supplier concentration risk. The methodology emphasized reproducibility through clear documentation of data sources, interview protocols, and assumptions underpinning qualitative judgments, enabling stakeholders to interrogate and adapt the findings to their specific contexts.

Concluding synthesis emphasizing the need for coordinated evidence generation, supply chain agility, and tailored commercialization to secure clinical and commercial success

This report synthesizes technical, clinical, regulatory, and commercial perspectives to present an integrated view of the detachable coil embolization landscape. Device innovation continues to advance detachment precision, coil morphology, and biocompatible coatings, while clinical adoption increasingly depends on demonstrable real-world outcomes and seamless procedural integration. Supply chain and policy shifts are adding layers of operational complexity, prompting manufacturers and providers to pursue diversified sourcing, evidence-based engagement, and service-oriented commercial models.

Looking forward, stakeholders that combine disciplined clinical evidence generation with pragmatic supply chain strategies and tailored product segmentation will be best positioned to navigate an evolving environment. Collaboration between device developers, clinical leaders, and procurement teams will be essential to align device capabilities with procedural needs and institutional constraints. The conclusion underscores the importance of adaptive strategies that balance innovation with operational resilience and a commitment to improving patient outcomes across diverse care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Detachable Coil Embolization System Market, by Delivery Mechanism

  • 8.1. Electrodetachable
    • 8.1.1. DC Electrodetachment
    • 8.1.2. Electrolytic Detachment
  • 8.2. Mechanical Detachable
    • 8.2.1. Micromechanical Clip
    • 8.2.2. Spring Loaded

9. Detachable Coil Embolization System Market, by Configuration

  • 9.1. Three D
    • 9.1.1. Complex Shape
    • 9.1.2. J Shape
  • 9.2. Two D
    • 9.2.1. Helical
    • 9.2.2. Straight

10. Detachable Coil Embolization System Market, by Coil Type

  • 10.1. Bare Platinum
  • 10.2. Bioactive
  • 10.3. Hydrogel Coated

11. Detachable Coil Embolization System Market, by End User

  • 11.1. Ambulatory Surgery Centers
  • 11.2. Hospitals
    • 11.2.1. Community Hospitals
    • 11.2.2. Teaching Hospitals

12. Detachable Coil Embolization System Market, by Application

  • 12.1. Cerebral Aneurysm
    • 12.1.1. Fusiform
    • 12.1.2. Saccular
  • 12.2. Peripheral Aneurysm
    • 12.2.1. Extremity
    • 12.2.2. Visceral

13. Detachable Coil Embolization System Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Detachable Coil Embolization System Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Detachable Coil Embolization System Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Detachable Coil Embolization System Market

17. China Detachable Coil Embolization System Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Acandis GmbH & Co. KG
  • 18.6. Asahi Intecc Co., Ltd.
  • 18.7. Balt Extrusion S.A.S.
  • 18.8. Boston Scientific Corporation
  • 18.9. Cerenovus, a Johnson & Johnson Company
  • 18.10. Cook Medical LLC
  • 18.11. Guerbet LLC
  • 18.12. Integer Holdings Corporation
  • 18.13. Johnson & Johnson
  • 18.14. Kaneka Corporation
  • 18.15. Lepu Medical Technology Co., Ltd.
  • 18.16. Medtronic plc
  • 18.17. Merit Medical Systems, Inc.
  • 18.18. MicroPort Scientific Corporation
  • 18.19. MicroVention, Inc.
  • 18.20. Penumbra, Inc.
  • 18.21. Shape Memory Medical, Inc.
  • 18.22. Stryker Corporation
  • 18.23. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DC ELECTRODETACHMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DC ELECTRODETACHMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DC ELECTRODETACHMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTROLYTIC DETACHMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTROLYTIC DETACHMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTROLYTIC DETACHMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MICROMECHANICAL CLIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MICROMECHANICAL CLIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MICROMECHANICAL CLIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SPRING LOADED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SPRING LOADED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SPRING LOADED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COMPLEX SHAPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COMPLEX SHAPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COMPLEX SHAPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY J SHAPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY J SHAPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY J SHAPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HELICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HELICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HELICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY STRAIGHT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY STRAIGHT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY STRAIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE PLATINUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE PLATINUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE PLATINUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TEACHING HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TEACHING HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TEACHING HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY FUSIFORM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY FUSIFORM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY FUSIFORM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SACCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SACCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SACCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY EXTREMITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY EXTREMITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY EXTREMITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY VISCERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY VISCERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY VISCERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 208. GCC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. GCC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 210. GCC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 211. GCC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 212. GCC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 213. GCC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 214. GCC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 215. GCC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. GCC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. GCC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 218. GCC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. GCC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 220. GCC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 247. G7 DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. G7 DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 249. G7 DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 250. G7 DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 251. G7 DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 252. G7 DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 253. G7 DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 254. G7 DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. G7 DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. G7 DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 257. G7 DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 258. G7 DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 259. G7 DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 260. NATO DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 261. NATO DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 262. NATO DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 263. NATO DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 264. NATO DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 265. NATO DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 266. NATO DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 267. NATO DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. NATO DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. NATO DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 270. NATO DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. NATO DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 272. NATO DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 273. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLIO